A detailed history of Brown Advisory Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 15,518 shares of CRL stock, worth $2.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,518
Previous 16,646 6.78%
Holding current value
$2.89 Million
Previous $3.44 Million 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $212,018 - $276,687
-1,128 Reduced 6.78%
15,518 $3.06 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $194,832 - $253,681
944 Added 6.01%
16,646 $3.44 Million
Q1 2024

Apr 24, 2024

BUY
$203.52 - $273.43 $197,007 - $264,680
968 Added 6.57%
15,702 $4.25 Million
Q4 2023

Feb 08, 2024

SELL
$164.52 - $238.84 $29,449 - $42,752
-179 Reduced 1.2%
14,734 $3.48 Million
Q3 2023

Oct 24, 2023

BUY
$194.44 - $217.61 $22,749 - $25,460
117 Added 0.79%
14,913 $2.92 Million
Q2 2023

Jul 31, 2023

SELL
$183.71 - $210.25 $28 Million - $32 Million
-152,194 Reduced 91.14%
14,796 $3.11 Million
Q1 2023

May 08, 2023

BUY
$191.89 - $259.92 $284,380 - $385,201
1,482 Added 0.9%
166,990 $33.7 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $3.81 Million - $4.83 Million
-19,315 Reduced 10.45%
165,508 $36 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $714,617 - $981,365
-3,917 Reduced 2.08%
184,823 $36.4 Million
Q2 2022

Nov 14, 2022

SELL
$204.13 - $302.4 $18.4 Million - $27.3 Million
-90,239 Reduced 32.35%
188,740 $40.4 Million
Q2 2022

Sep 13, 2022

SELL
$204.13 - $302.4 $771,203 - $1.14 Million
-3,778 Reduced 2.0%
184,863 $39.6 Million
Q2 2022

Aug 02, 2022

SELL
$204.13 - $302.4 $17 Million - $25.2 Million
-83,291 Reduced 30.63%
188,641 $42 Million
Q1 2022

Nov 14, 2022

BUY
$255.51 - $362.11 $24 Million - $34.1 Million
94,116 Added 50.91%
278,979 $79.2 Million
Q1 2022

Sep 13, 2022

SELL
$255.51 - $362.11 $887,130 - $1.26 Million
-3,472 Reduced 1.26%
271,932 $77.2 Million
Q1 2022

May 09, 2022

SELL
$255.51 - $362.11 $92.9 Million - $132 Million
-363,731 Reduced 56.91%
275,404 $79.1 Million
Q4 2021

Jan 27, 2022

SELL
$351.38 - $448.68 $16.9 Million - $21.6 Million
-48,216 Reduced 7.01%
639,135 $241 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $31.7 Million - $39 Million
-85,090 Reduced 11.02%
687,351 $284 Million
Q2 2021

Jul 29, 2021

SELL
$294.17 - $371.65 $32.1 Million - $40.6 Million
-109,207 Reduced 12.39%
772,441 $286 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $6.16 Million - $7.39 Million
24,669 Added 2.88%
881,648 $256 Million
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $737,928 - $839,708
-3,324 Reduced 0.39%
856,979 $214 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $22.2 Million - $28.6 Million
-126,332 Reduced 12.8%
860,303 $195 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $6.27 Million - $10 Million
52,733 Added 5.65%
986,635 $172 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $1.67 Million - $3.01 Million
16,904 Added 1.84%
933,902 $118 Million
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $765,249 - $927,405
6,071 Added 0.67%
916,998 $140 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $7.88 Million - $9.05 Million
63,007 Added 7.43%
910,927 $121 Million
Q2 2019

Aug 12, 2019

BUY
$123.4 - $148.55 $76,014 - $91,506
616 Added 0.07%
847,920 $120 Million
Q1 2019

May 15, 2019

BUY
$104.82 - $146.73 $5.04 Million - $7.05 Million
48,076 Added 6.02%
847,304 $123 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $805,304 - $1.05 Million
7,663 Added 0.97%
799,228 $90.5 Million
Q3 2018

Nov 13, 2018

BUY
$112.11 - $134.54 $9.99 Million - $12 Million
89,065 Added 12.68%
791,565 $106 Million
Q2 2018

Aug 10, 2018

BUY
$102.37 - $117.25 $3.71 Million - $4.25 Million
36,219 Added 5.44%
702,500 $78.9 Million
Q1 2018

Jun 28, 2018

BUY
$98.19 - $115.2 $27.6 Million - $32.4 Million
281,435 Added 73.13%
666,281 $71.1 Million
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $26.4 Million - $31 Million
-269,208 Reduced 41.16%
384,846 $41.1 Million
Q4 2017

Feb 12, 2018

SELL
$100.43 - $118.09 $3.05 Million - $3.58 Million
-30,342 Reduced 4.43%
654,054 $71.6 Million
Q3 2017

Nov 13, 2017

SELL
$96.72 - $109.26 $8.37 Million - $9.45 Million
-86,523 Reduced 11.22%
684,396 $73.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
770,919
770,919 $78 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.